GPRC5S x CD3 bispecific antibodies

被引：0
|
作者：
Stretton, Owen
机构：
来源：
LANCET HAEMATOLOGY | 2022年 / 9卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E558 / E558
页数：1
相关论文
共 50 条
  • [1] Bispecific antibodies targeting CD3 in oncology and hematology
    Vanacker, Helene
    Vinceneux, Armelle
    Nicolas-Virelizier, Emmanuelle
    Brahmi, Mehdi
    Cassier, Philippe A.
    BULLETIN DU CANCER, 2021, 108 (10) : S181 - S194
  • [2] Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (αEpCAM x αCD3)
    Riesenberg, R
    Buchner, A
    Pohla, H
    Lindhofer, H
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2001, 49 (07) : 911 - 917
  • [3] Current landscape of CD3 bispecific antibodies in hematologic malignancies
    Kassner, Joshua
    Abdellatif, Basma
    Yamshon, Samuel
    Monge, Jorge
    Kaner, Justin
    TRENDS IN CANCER, 2024, 10 (08) : 708 - 732
  • [4] Targeting Solid Tumors Using CD3 Bispecific Antibodies
    Crawford, Alison
    Chiu, Danica
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (08) : 1350 - 1358
  • [5] Taste Abnormalities Emerging during Anti- Myeloma Therapies Including GPRC5D x CD3 Bispecific Antibody Talquetamab
    Fleischer, Anna
    Roll, Magdalena
    Panther, Franziska
    Gelbrich, Goetz
    Reinhardt, Franziska
    Riedhammer, Christine
    Mersi, Julia
    Waldschmidt, Johannes M.
    Einsele, Hermann
    Kortuem, K. Martin
    Maatouk, Imad
    Rasche, Leo
    BLOOD, 2023, 142
  • [6] Anti-GPRC5D/CD3 Bispecific T-Cell-Redirecting Antibody for the Treatment of Multiple Myeloma
    Kodama, Tatsushi
    Kochi, Yu
    Nakai, Waka
    Mizuno, Hideaki
    Baba, Takeshi
    Habu, Kiyoshi
    Sawada, Noriaki
    Tsunoda, Hiroyuki
    Shima, Takahiro
    Miyawaki, Kohta
    Kikushige, Yoshikane
    Mori, Yasuo
    Miyamoto, Toshihiro
    Maeda, Takahiro
    Akashi, Koichi
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (09) : 1555 - 1564
  • [7] Activity of CD19/CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia
    Robinson, Hannah R.
    Qi, Junpeng
    Baskar, Sivasubramanian
    Cook, Erika
    Ahn, Inhye E.
    Herman, Sarah E. M.
    Rader, Christoph
    Wiestner, Adrian
    BLOOD, 2017, 130
  • [8] A novel mouse model for preclinical efficacy evaluation of anti-CD3/GPRC5D bispecific antibodies
    Yang, Xiaoliu
    Liang, Xinyuan
    Zhang, Mingkun
    Chen, Santi Suryani
    Li, Zhiying
    Trujillo, Erica
    Moore, Mark Wade
    Zhao, Jing
    Gao, Xiang
    Ju, Cunxiang
    CANCER RESEARCH, 2023, 83 (07)
  • [9] FDA approves first GPRC5D x CD3-targeted bispecific for multiple myeloma
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (10) : 775 - 775
  • [10] Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases
    Huang, Hongpeng
    Wei, Xuetao
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2025, 5 (04): : 209 - 216
12345